Literature DB >> 9086177

Synthetic NGF peptide derivatives prevent neuronal death via a p75 receptor-dependent mechanism.

F M Longo1, M Manthorpe, Y M Xie, S Varon.   

Abstract

Cyclized peptides corresponding to beta-loop regions of NGF were purified by HPLC and assayed for neurotrophic activity using DRG neurons. Peptides with the highest activity corresponded to loop region 29-35, a domain likely to interact with the p75 receptor. Unexpectedly, activity was confined to late-eluting HPLC fractions containing peptide multimers and primarily promoted neuronal survival without neurite outgrowth. Directed synthesis of dimer and monomer cyclized peptides demonstrated that dimers acted as partial NGF agonists in that they had both survival-promoting and NGF-inhibiting activity while monomer and linear peptides were inactive. Dimer activity was not affected by the Trk inhibitor K252a but was blocked by p75 receptor antibody and absent using p75 null mutant neurons. These studies suggest that region 29-35 peptide derivatives inhibit neuronal death via a structure- and p75-dependent mechanism.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9086177     DOI: 10.1002/(sici)1097-4547(19970401)48:1<1::aid-jnr1>3.0.co;2-k

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  18 in total

1.  Alzheimer's therapeutics: neurotrophin domain small molecule mimetics.

Authors:  Stephen M Massa; Youmei Xie; Frank M Longo
Journal:  J Mol Neurosci       Date:  2003       Impact factor: 3.444

2.  Novel low-molecular-weight mimetics of the nerve growth factor.

Authors:  T A Gudasheva; T A Antipova; S B Seredenin
Journal:  Dokl Biochem Biophys       Date:  2010-10-20       Impact factor: 0.788

3.  Absence of p75NTR causes increased basal forebrain cholinergic neuron size, choline acetyltransferase activity, and target innervation.

Authors:  T T Yeo; J Chua-Couzens; L L Butcher; D E Bredesen; J D Cooper; J S Valletta; W C Mobley; F M Longo
Journal:  J Neurosci       Date:  1997-10-15       Impact factor: 6.167

4.  Dependence receptors: mechanisms of an announced death.

Authors:  Chantal Thibert; Joanna Fombonne
Journal:  Cell Cycle       Date:  2010-06-01       Impact factor: 4.534

Review 5.  Neuroprotective strategies in Alzheimer's disease.

Authors:  Frank M Longo; Stephen M Massa
Journal:  NeuroRx       Date:  2004-01

6.  Mapping the active site in vasoactive intestinal peptide to a core of four amino acids: neuroprotective drug design.

Authors:  I Gozes; O Perl; E Giladi; A Davidson; O Ashur-Fabian; S Rubinraut; M Fridkin
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

7.  Bivalent diketopiperazine-based tropomysin receptor kinase C (TrkC) antagonists.

Authors:  Jing Liu; Fouad Brahimi; H Uri Saragovi; Kevin Burgess
Journal:  J Med Chem       Date:  2010-07-08       Impact factor: 7.446

8.  Bivalent peptidomimetic ligands of TrkC are biased agonists and selectively induce neuritogenesis or potentiate neurotrophin-3 trophic signals.

Authors:  Dianjun Chen; Fouad Brahimi; Yu Angell; Yu-Chin Li; Jennifer Moscowicz; H Uri Saragovi; Kevin Burgess
Journal:  ACS Chem Biol       Date:  2009-09-18       Impact factor: 5.100

9.  Alzheimer's therapeutics: neurotrophin small molecule mimetics.

Authors:  Stephen M Massa; Youmei Xie; Frank M Longo
Journal:  J Mol Neurosci       Date:  2002 Aug-Oct       Impact factor: 3.444

Review 10.  Small-molecule modulation of neurotrophin receptors: a strategy for the treatment of neurological disease.

Authors:  Frank M Longo; Stephen M Massa
Journal:  Nat Rev Drug Discov       Date:  2013-07       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.